Phosphorylation of eukaryotic initiation factor-2α (eIF2α) is associated with neuronal degeneration in Alzheimerʼs disease

PKR; a sentinel kinase for cellular stress

Williams, B. R. (1999) · Oncogene · doi:10.1038/sj.onc.1203127 · Cited by 820

Regulation of starvation- and virus-induced autophagy by the eIF2α kinase signaling pathway

Tallóczy, Z., Jiang, W., Virgin, H. W., Leib, D. A., Scheuner, D., Kaufman, R. J., Eskelinen, E., & Levine, B. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.012485299 · Cited by 757

Activation of Caspase-3 in Single Neurons and Autophagic Granules of Granulovacuolar Degeneration in Alzheimer's Disease

Stadelmann, C., Deckwerth, T. L., Srinivasan, A. N., Bancher, C., Brück, W., Jellinger, K. A., & Lassmann, H. (1999) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65460-0 · Cited by 432

Suppression of protein synthesis in brain during hibernation involves inhibition of protein initiation and elongation

Frerichs, K. U., Smith, C. B., Brenner, M., DeGracia, D. J., Krause, G. S., Marrone, L., Dever, T. E., & Hallenbeck, J. M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.24.14511 · Cited by 326

Activated caspase-3 expression in Alzheimer’s and aged control brain: correlation with Alzheimer pathology

Su, J. H., Zhao, M., Anderson, A. J., Srinivasan, A. N., & Cotman, C. W. (2001) · Brain Research · doi:10.1016/s0006-8993(01)02018-2 · Cited by 260

Brain ischemia and reperfusion activates the eukaryotic initiation factor 2α kinase, PERK

Kumar, R., Azam, S. M., Sullivan, J. M., Owen, C. R., Cavener, D. R., Zhang, P., Ron, D., Harding, H. P., Chen, J.-J., Han, A., et al. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00387.x · Cited by 212

The active form of glycogen synthase kinase-3? is associated with granulovacuolar degeneration in neurons in Alzheimer's disease

Boutajangout, A., Leroy, K., Authelet, M., Anderton, B. H., Brion, J., & Woodgett, J. R. (2002) · Acta Neuropathologica · doi:10.1007/s004010100435 · Cited by 190

Involvement of double‐stranded RNA‐dependent protein kinase and phosphorylation of eukaryotic initiation factor‐2α in neuronal degeneration

Chang, R. C., Suen, K., Ma, C., Elyaman, W., Ng, H., & Hugon, J. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.01237.x · Cited by 180

Translation Inhibition in Apoptosis

Saelens, X., Kalai, M., & Vandenabeele, P. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103674200 · Cited by 177

In Situ Immunodetection of Neuronal Caspase-3 Activation in Alzheimer Disease

Selznick, L. A., Holtzman, D. M., Han, B. H., Gökden, M., Srinivasan, A. N., Johnson, E. M., & Roth, K. A. (1999) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199909000-00012 · Cited by 160

The integrated stress response: From mechanism to disease

Costa-Mattioli, M., & Walter, P. (2020) · Science · doi:10.1126/science.aat5314 · Cited by 1,617

Molecular Interplay between Mammalian Target of Rapamycin (mTOR), Amyloid-β, and Tau

Caccamo, A., Majumder, S., Richardson, A., Strong, R., & Oddo, S. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.100420 · Cited by 881

Autophagy: in sickness and in health

Cuervo, A. M. (2004) · Trends in Cell Biology · doi:10.1016/j.tcb.2003.12.002 · Cited by 828

Suppression of eIF2α kinases alleviates Alzheimer's disease–related plasticity and memory deficits

Ma, T., Trinh, M. A., Wexler, A. J., Bourbon, C., Gatti, E., Pierre, P., Cavener, D. R., & Klann, E. (2013) · Nature Neuroscience · doi:10.1038/nn.3486 · Cited by 575

The unfolded protein response is activated in Alzheimer’s disease

Hoozemans, J. J. M., Veerhuis, R., van Haastert, E. S., Rozemüller, A. J. M., Baas, F., Eikelenboom, P., & Scheper, W. (2005) · Acta Neuropathologica · doi:10.1007/s00401-005-1038-0 · Cited by 549

Ribosome Dysfunction Is an Early Event in Alzheimer's Disease

Ding, Q., Markesbery, W. R., Chen, Q., Li, F., & Keller, J. N. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.3040-05.2005 · Cited by 433

Inducing Autophagy by Rapamycin Before, but Not After, the Formation of Plaques and Tangles Ameliorates Cognitive Deficits

Majumder, S., Richardson, A., Strong, R., & Oddo, S. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025416 · Cited by 365

Lipid peroxidation and neurodegenerative disease

Reed, T. T. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.06.027 · Cited by 385

Soluble amyloid-β oligomers as synaptotoxins leading to cognitive impairment in Alzheimer’s disease

Ferreira, S. T., Lourenco, M. V., Oliveira, M. M., & De Felice, F. G. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00191 · Cited by 373

Translational control in synaptic plasticity and cognitive dysfunction

Buffington, S. A., Huang, W., & Costa-Mattioli, M. (2014) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-071013-014100 · Cited by 348

mTOR regulates tau phosphorylation and degradation: implications for Alzheimer's disease and other tauopathies

Caccamo, A., Magrì, A., Medina, D. X., Wisely, E. V., López‐Aranda, M. F., Silva, A. J., & Oddo, S. (2013) · Aging Cell · doi:10.1111/acel.12057 · Cited by 362

Use of Anti-aging Herbal Medicine, Lycium barbarum, Against Aging-associated Diseases. What Do We Know So Far?

Chang, R. C., & So, K. (2007) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-007-9181-x · Cited by 334

Mammalian/mechanistic target of rapamycin (mTOR) complexes in neurodegeneration

Querfurth, H., & Lee, H.-K. (2021) · Molecular Neurodegeneration · doi:10.1186/s13024-021-00428-5 · Cited by 288

A non-canonical cGAS–STING–PERK pathway facilitates the translational program critical for senescence and organ fibrosis

Zhang, D., Liu, Y., Zhu, Y., Zhang, Q. Y., Guan, H., Liu, S., Chen, S., Chen, M., Chen, C., Liao, Z., et al. (2022) · Nature Cell Biology · doi:10.1038/s41556-022-00894-z · Cited by 301

Minocycline Attenuates Neuronal Cell Death and Improves Cognitive Impairment in Alzheimer's Disease Models

Choi, Y., Kim, H., Shin, K. Y., Kim, E., Kim, M., Kim, H.-S., Park, C. H., Jeong, Y. H., Yoo, J., Lee, J., et al. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301377 · Cited by 296

The ER stress factor XBP1s prevents amyloid-β neurotoxicity

Casas-Tinto, S., Zhang, Y., Sanchez-Garcia, J., Gomez-Velazquez, M., Rincon-Limas, D. E., & Fernandez-Funez, P. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr100 · Cited by 275

Redox proteomic identification of 4-Hydroxy-2-nonenal-modified brain proteins in amnestic mild cognitive impairment: Insight into the role of lipid peroxidation in the progression and pathogenesis of Alzheimer's disease

Reed, T., Perluigi, M., Sultana, R., Pierce, W. M., Klein, J. B., Turner, D. M., Coccia, R., Markesbery, W. R., & Butterfield, D. A. (2008) · Neurobiology of Disease · doi:10.1016/j.nbd.2007.12.007 · Cited by 257

Altered Machinery of Protein Synthesis in Alzheimer's: From the Nucleolus to the Ribosome

Hernández‐Ortega, K., Garcia‐Esparcia, P., Gil, L., Lucas, J. J., & Ferrer, I. (2016) · Brain Pathology · doi:10.1111/bpa.12335 · Cited by 245

Endoplasmic reticulum stress features are prominent in Alzheimer disease but not in prion diseases in vivo

Unterberger, U., Höftberger, R., Gelpi, E., Flicker, H., Budka, H., & Voigtländer, T. (2006) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/01.jnen.0000218445.30535.6f · Cited by 237

Phenylbutyrate rescues dendritic spine loss associated with memory deficits in a mouse model of Alzheimer disease

Ricobaraza, A., Cuadrado‐Tejedor, M., Marco, S., Pérez‐Otaño, I., & García‐Osta, A. (2012) · Hippocampus · doi:10.1002/hipo.20883 · Cited by 239

The role of mTOR signaling in Alzheimer disease

Oddo, S. (2012) · Frontiers in Bioscience-Scholar · doi:10.2741/s310 · Cited by 243

The role of endoplasmic reticulum stress in neurodegenerative disease

Xiang, C., Wang, Y., Zhang, H., & Han, F. (2016) · APOPTOSIS · doi:10.1007/s10495-016-1296-4 · Cited by 235

Oxidatively modified proteins in Alzheimer’s disease (AD), mild cognitive impairment and animal models of AD: role of Abeta in pathogenesis

Sultana, R., Perluigi, M., & Butterfield, D. A. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0517-0 · Cited by 215

Arctigenin Effectively Ameliorates Memory Impairment in Alzheimer's Disease Model Mice Targeting Both -Amyloid Production and Clearance

Zhu, Z., Yan, J., Jiang, W., Yao, X., Chen, J., Chen, L., Li, C., Hu, L., Jiang, H., & Shen, X. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.4790-12.2013 · Cited by 207

Regulation of mRNA Translation in Neurons—A Matter of Life and Death

Kapur, M., Monaghan, C. E., & Ackerman, S. L. (2017) · Neuron · doi:10.1016/j.neuron.2017.09.057 · Cited by 208

Neuroprotective effects of anti-aging oriental medicine Lycium barbarum against β-amyloid peptide neurotoxicity

Yu, M.-S., Leung, S. K., Lai, S.-W., Che, C., Zee, S., So, K., Yuen, W.-H., & Chang, R. C. (2005) · Experimental Gerontology · doi:10.1016/j.exger.2005.06.010 · Cited by 203

Activation of the Unfolded Protein Response Is an Early Event in Alzheimer’s and Parkinson’s Disease

Hoozemans, J. J. M., van Haastert, E. S., Nijholt, D. A. T., Rozemüller, A. J. M., & Scheper, W. (2012) · Neurodegenerative Diseases · doi:10.1159/000334536 · Cited by 202

mTOR‐dependent signalling in Alzheimer's disease

Pei, J., & Hugon, J. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00509.x · Cited by 190

mTOR/p70S6k signalling alteration by Aβ exposure as well as in APP‐PS1 transgenic models and in patients with Alzheimer's disease

Lafay‐Chebassier, C., Paccalin, M., Page, G., Barc‐Pain, S., Perault‐Pochat, M. C., Gil, R., Pradier, L., & Hugon, J. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03187.x · Cited by 211

Genetic Reduction of Mammalian Target of Rapamycin Ameliorates Alzheimer's Disease-Like Cognitive and Pathological Deficits by Restoring Hippocampal Gene Expression Signature

Caccamo, A., Pinto, V. D., Messina, A. A., Branca, C., & Oddo, S. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.0777-14.2014 · Cited by 186

Oxidative stress increases BACE1 protein levels through activation of the PKR-eIF2α pathway

Mouton‐Liger, F., Paquet, C., Dumurgier, J., Bouras, C., Pradier, L., Gray, F., & Hugon, J. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.01.009 · Cited by 174

Basal Levels of eIF2α Phosphorylation Determine Cellular Antioxidant Status by Regulating ATF4 and xCT Expression

Lewerenz, J., & Maher, P. A. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m807325200 · Cited by 173

Naturally Secreted Amyloid-β Increases Mammalian Target of Rapamycin (mTOR) Activity via a PRAS40-mediated Mechanism

Caccamo, A., Maldonado, M. A., Majumder, S., Medina, D. X., Holbein, W. W., Magrì, A., & Oddo, S. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.180638 · Cited by 186

Activation of the integrated stress response during T helper cell differentiation

Scheu, S., Stetson, D. B., Reinhardt, R. L., Leber, J. H., Mohrs, M., & Locksley, R. M. (2006) · Nature Immunology · doi:10.1038/ni1338 · Cited by 171

PERK mediates eIF2α phosphorylation responsible for BACE1 elevation, CREB dysfunction and neurodegeneration in a mouse model of Alzheimer's disease

Devi, L., & Ohno, M. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.04.031 · Cited by 169

Molecular Mechanisms of ER Stress and UPR in the Pathogenesis of Alzheimer’s Disease

Uddin, M. S., Tewari, D., Sharma, G., Kabir, M. T., Barreto, G. E., Bin-Jumah, M. N., Perveen, A., Abdel‐Daim, M. M., & Ashraf, G. M. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-01929-y · Cited by 166

Activation of mTOR: a culprit of Alzheimer’s disease?

Cai, Z., Zhou, Y., Xiao, M., Yan, L.-J., & He, W. (2015) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s75717 · Cited by 161

What is behind the non-antibiotic properties of minocycline?

Garrido‐Mesa, N., Zarzuelo, A., & Gálvez, J. (2012) · Pharmacological Research · doi:10.1016/j.phrs.2012.10.006 · Cited by 158

Mechanisms Underlying Insulin Deficiency-Induced Acceleration of β-Amyloidosis in a Mouse Model of Alzheimer's Disease

Devi, L., Alldred, M. J., Ginsberg, S. D., & Ohno, M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032792 · Cited by 159

Endogenously Nitrated Proteins in Mouse Brain: Links to Neurodegenerative Disease

Sacksteder, C. A., Qian, W., Knyushko, T. V., Wang, H., Chin, M. H., Laćan, G., Melega, W. P., Camp, D., Smith, R. D., Smith, D., et al. (2006) · Biochemistry · doi:10.1021/bi060474w · Cited by 151

Correction of eIF2-dependent defects in brain protein synthesis, synaptic plasticity, and memory in mouse models of Alzheimer’s disease

Oliveira, M. M., Lourenco, M. V., Longo, F., Kasica, N. P., Yang, W., Ureta, G., Ferreira, D. D. P., Mendonça, P. H. J., Bernales, S., Ma, T., et al. (2021) · Science Signaling · doi:10.1126/scisignal.abc5429 · Cited by 149

Phospho-eIF2α Level Is Important for Determining Abilities of BACE1 Reduction to Rescue Cholinergic Neurodegeneration and Memory Defects in 5XFAD Mice

Devi, L., & Ohno, M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012974 · Cited by 140

Translational Control in the Brain in Health and Disease

Sossin, W. S., & Costa-Mattioli, M. (2019) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a032912 · Cited by 138

An Unbiased Approach to Identifying Tau Kinases That Phosphorylate Tau at Sites Associated with Alzheimer Disease

Cavallini, A., Brewerton, S., Bell, A., Sargent, S., Glover, S., Hardy, C., Moore, R., Calley, J., Ramachandran, D., Poidinger, M., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.463984 · Cited by 133

Proteomic Quantification and Site-Mapping of S -Nitrosylated Proteins Using Isobaric iodoTMT Reagents

Qu, Z., Meng, F., Bomgarden, R. D., Viner, R., Li, J., Rogers, J. C., Cheng, J., Greenlief, C. M., Cui, J., Lubahn, D. B., et al. (2014) · Journal of Proteome Research · doi:10.1021/pr401179v · Cited by 132

The Integrated Stress Response and Phosphorylated Eukaryotic Initiation Factor 2α in Neurodegeneration

Newton, S. E. B., Lloreda, C. L., Gannon, P. J., Akay, C., & Jordan‐Sciutto, K. L. (2020) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlz129 · Cited by 139

Sex- and brain region-specific acceleration of β-amyloidogenesis following behavioral stress in a mouse model of Alzheimer's disease

Devi, L., Alldred, M. J., Ginsberg, S. D., & Ohno, M. (2010) · Molecular Brain · doi:10.1186/1756-6606-3-34 · Cited by 129

Impaired protein translation in Drosophila models for Charcot–Marie–Tooth neuropathy caused by mutant tRNA synthetases

Niehues, S., Bussmann, J., Steffes, G., Erdmann, I., Köhrer, C., Sun, L., Wagner, M., Schäfer, K. J., Wang, G., Koerdt, S. N., et al. (2015) · Nature Communications · doi:10.1038/ncomms8520 · Cited by 122

Targeting the unfolded protein response in neurodegeneration: A new approach to therapy

Halliday, M., & Mallucci, G. R. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.08.034 · Cited by 125

Activation of the cell stress kinase PKR in Alzheimer's disease and human amyloid precursor protein transgenic mice

Peel, A. (2003) · Neurobiology of Disease · doi:10.1016/s0969-9961(03)00086-x · Cited by 125

Roles of eIF2α kinases in the pathogenesis of Alzheimer’s disease

Ohno, M. (2014) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2014.00022 · Cited by 123

Roles of 3-nitrotyrosine- and 4-hydroxynonenal-modified brain proteins in the progression and pathogenesis of Alzheimer's disease

Butterfield, D. A., Reed, T. T., & Rukhsana Sultana, A. (2010) · Free Radical Research · doi:10.3109/10715762.2010.520014 · Cited by 125

Double-strand RNA dependent protein kinase (PKR) is involved in the extrastriatal degeneration in Parkinson's disease and Huntington's disease

BANDO, Y., ONUKI, R., KATAYAMA, T., MANABE, T., KUDO, T., TAIRA, K., & TOHYAMA, M. (2005) · Neurochemistry International · doi:10.1016/j.neuint.2004.07.005 · Cited by 126

Brain metabolic stress and neuroinflammation at the basis of cognitive impairment in Alzheimer’s disease

Felice, F. G. D., & Lourenco, M. V. (2015) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2015.00094 · Cited by 122

Genome-wide Association Study of Normal Tension Glaucoma: Common Variants in SRBD1 and ELOVL5 Contribute to Disease Susceptibility

⁎ (2010) · Ophthalmology · doi:10.1016/j.ophtha.2009.12.001 · Cited by 121

The role of endoplasmic reticulum in amyloid precursor protein processing and trafficking: Implications for Alzheimer's disease

Plácido, A. I., Pereira, C., Duarte, A. I., Candeias, E., Correia, S. C., Santos, R. X., Carvalho, C., Cardoso, S. M., Oliveira, C. R., & Moreira, P. I. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.05.003 · Cited by 119

The unfolded protein response in Alzheimer’s disease

Cornejo, V. H., & Hetz, C. A. (2013) · Seminars in Immunopathology · doi:10.1007/s00281-013-0373-9 · Cited by 123

Activation of PERK Elicits Memory Impairment through Inactivation of CREB and Downregulation of PSD95 After Traumatic Brain Injury

Sen, T., Gupta, R. K., Kaiser, H., & Sen, N. (2017) · Journal of Neuroscience · doi:10.1523/jneurosci.2343-16.2017 · Cited by 115

Activated double-stranded RNA-dependent protein kinase and neuronal death in models of Alzheimer’s disease

Page, G., Rioux Bilan, A., Ingrand, S., Lafay-Chebassier, C., Pain, S., Perault Pochat, M. C., Bouras, C., Bayer, T., & Hugon, J. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.01.047 · Cited by 116

The Unfolded Protein Response in Vanishing White Matter Disease

van der Voorn, J. P., van Kollenburg, B., Bertrand, G. A. M., van Haren, K. P., Scheper, G. C., Powers, J. M., & van der Knaap, M. S. (2005) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/01.jnen.0000178446.41595.3a · Cited by 102

Neurodegeneration of the retina in mouse models of Alzheimer’s disease: what can we learn from the retina?

Chiu, K., Chan, T. F., Wu, A., Leung, I. Y.-P., So, K., & Chang, R. C. (2011) · AGE · doi:10.1007/s11357-011-9260-2 · Cited by 100

A neurodegenerative cellular stress response linked to dark microglia and toxic lipid secretion

Flury, A. G., Aljayousi, L., Park, H.-J., Khakpour, M., Mechler, J., Aziz, S., McGrath, J. D., Deme, P., Sandberg, C., Ibáñez, F. G., et al. (2024) · Neuron · doi:10.1016/j.neuron.2024.11.018 · Cited by 102

Metformin for Cardiovascular Protection, Inflammatory Bowel Disease, Osteoporosis, Periodontitis, Polycystic Ovarian Syndrome, Neurodegeneration, Cancer, Inflammation and Senescence: What Is Next?

Ala, M., & Ala, M. (2021) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.1c00167 · Cited by 97

Characterization of the effects of anti-aging medicine Fructus lycii on β-amyloid peptide neurotoxicity

Yu, M.-S., Lai, C. S.-W., Ho, J. Y. S., Zee, S., So, K., Yuen, W.-H., & Chang, R. C. (2007) · International Journal of Molecular Medicine · doi:10.3892/ijmm.20.2.261 · Cited by 95

Neuroinflammation and Aβ Accumulation Linked To Systemic Inflammation Are Decreased By Genetic PKR Down-Regulation

Carret‐Rebillat, A., Pace, C., Gourmaud, S., Ravasi, L., Montagne-Stora, S., Longueville, S., Tible, M., Sudol, E., Chang, R. C., Paquet, C., et al. (2015) · Scientific Reports · doi:10.1038/srep08489 · Cited by 100

Oxidative Damage, Protein Synthesis, and Protein Degradation in Alzheimers Disease

Ding, Q., Dimayuga, E. R., & Keller, J. N. (2007) · Current Alzheimer Research · doi:10.2174/156720507779939788 · Cited by 95

Upstream Signaling Pathways Leading to the Activation of Double-stranded RNA-dependent Serine/Threonine Protein Kinase in β-Amyloid Peptide Neurotoxicity

Suen, K.-C., Yu, M.-S., So, K.-F., Chang, R. C.-C., & Hugon, J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m306503200 · Cited by 95

Antagonizing β-amyloid peptide neurotoxicity of the anti-aging fungus Ganoderma lucidum

Lai, C. S.-W., Yu, M.-S., Yuen, W.-H., So, K., Zee, S., & Chang, R. C. (2007) · Brain Research · doi:10.1016/j.brainres.2007.10.103 · Cited by 93

Endoplasmic Reticulum Protein Quality Control in Neurodegenerative Disease: The Good, the Bad and the Therapy

Scheper, W., & Hoozemans, J. J. M. (2009) · Current Medicinal Chemistry · doi:10.2174/092986709787458506 · Cited by 92

The oxindole/imidazole derivative C16 reduces in vivo brain PKR activation

Ingrand, S., Barrier, L., Lafay-Chebassier, C., Fauconneau, B., Page, G., & Hugon, J. (2007) · FEBS Letters · doi:10.1016/j.febslet.2007.08.022 · Cited by 80

High-content siRNA screening of the kinome identifies kinases involved in Alzheimer's disease-related tau hyperphosphorylation

Azorsa, D. O., Robeson, R. H., Frost, D., hoovet, B. M., Brautigam, G. R., Dickey, C., Beaudry, C., Basu, G. D., Holz, D. R., Hernandez, J. A., et al. (2010) · BMC Genomics · doi:10.1186/1471-2164-11-25 · Cited by 88

Metabolic Dysfunction in Alzheimer’s Disease: From Basic Neurobiology to Clinical Approaches

Clarke, J. R., Ribeiro, F. C., Frozza, R. L., Felice, F. G. D., & Lourenco, M. V. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-179911 · Cited by 93

Activated mTOR and PKR Kinases in Lymphocytes Correlate with Memory and Cognitive Decline in Alzheimer’s Disease

Paccalin, M., Pain-Barc, S., Pluchon, C., Paul, C., Besson, M.-N., Carret-Rebillat, A.-S., Rioux-Bilan, A., Gil, R., & Hugon, J. (2006) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000095562 · Cited by 96

Novel neuroprotective effects of the aqueous extracts from Verbena officinalis Linn

Lai, S.-W., Yu, M.-S., Yuen, W.-H., & Chang, R. C. (2006) · Neuropharmacology · doi:10.1016/j.neuropharm.2005.11.009 · Cited by 85

PKR involvement in Alzheimer’s disease

Hugon, J., Mouton‐Liger, F., Dumurgier, J., & Paquet, C. (2017) · Alzheimer s Research & Therapy · doi:10.1186/s13195-017-0308-0 · Cited by 86

RAX, the PKR activator, sensitizes cells to inflammatory cytokines, serum withdrawal, chemotherapy, and viral infection

Bennett, R. L., Blalock, W. L., Abtahi, D., Pan, Y., Moyer, S. A., & May, W. S. (2006) · Blood · doi:10.1182/blood-2005-11-006817 · Cited by 81

Dysfunctional Pro-Ceramide, ER Stress, and Insulin/IGF Signaling Networks with Progression of Alzheimer's Disease

de la Monte, S. M., Re, E. B., Longato, L., & Tong, M. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-111728 · Cited by 81

Endoplasmic reticulum stress responses in mouse models of Alzheimer's disease: Overexpression paradigm versus knockin paradigm

Hashimoto, S., Ishii, A., Kamano, N., Watamura, N., Saito, T., Ohshima, T., Yokosuka, M., & Saido, T. C. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.811315 · Cited by 79

Aging: All roads lead to mitochondria

Son, J. M., & Lee, C. D. (2021) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2021.02.006 · Cited by 86

APOE4 confers transcriptomic and functional alterations to primary mouse microglia

Machlovi, S. I., Neuner, S. M., Hemmer, B. M., Khan, R., Liu, Y., Huang, M., Zhu, J. D., Castellano, J. M., Cai, D., Marcora, E., et al. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105615 · Cited by 73

A comprehensive multiomics approach toward understanding the relationship between aging and dementia

Currais, A. J. M., Goldberg, J., Farrokhi, C. B., Chang, M. W., Prior, M., Dargusch, R., Daugherty, D., Armando, A. M., Quehenberger, O., Maher, P. A., et al. (2015) · Aging · doi:10.18632/aging.100838 · Cited by 77

Neuronal Regulation of eIF2α Function in Health and Neurological Disorders

Moon, S. L., Sonenberg, N., & Parker, R. (2018) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2018.04.001 · Cited by 76

Neuronal stress signaling and eIF2α phosphorylation as molecular links between Alzheimer's disease and diabetes

Lourenco, M. V., Ferreira, S. T., & Felice, F. G. D. (2015) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.03.003 · Cited by 74

ApoE ε4 is associated with eIF2α phosphorylation and impaired learning in young mice

Segev, Y., Michaelson, D. M., & Rosenblum, K. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.06.020 · Cited by 72

Distinct roles of protein kinase R and toll‐like receptor 3 in the activation of astrocytes by viral stimuli

Carpentier, P. A., Williams, B. R. G., & Miller, S. D. (2006) · Glia · doi:10.1002/glia.20450 · Cited by 70

GLP-1 Receptor Agonists in Neurodegeneration: Neurovascular Unit in the Spotlight

Monti, G., Moreira, D. G., Richner, M., Mutsaers, H. A. M., Ferreira, N., & Jan, A. (2022) · Cells · doi:10.3390/cells11132023 · Cited by 72

Modulation of Tau Phosphorylation by the Kinase PKR: Implications in Alzheimer's Disease

Bose, A., Mouton‐Liger, F., Paquet, C., Mazot, P., Vigny, M., Gray, F., & Hugon, J. (2010) · Brain Pathology · doi:10.1111/j.1750-3639.2010.00437.x · Cited by 72

Human Immunodeficiency Virus-1/Surface Glycoprotein 120 Induces Apoptosis through RNA-Activated Protein Kinase Signaling in Neurons

Alirezaei, M., Watry, D. D., Flynn, C. F., Kiosses, W. B., Masliah, E., Williams, B. R. G., Kaul, M., Lipton, S. A., & Fox, H. S. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.2733-07.2007 · Cited by 67

The mammalian target of rapamycin at the crossroad between cognitive aging and Alzheimer’s disease

Talboom, J. S., Velázquez, R., & Oddo, S. (2015) · npj Aging and Mechanisms of Disease · doi:10.1038/npjamd.2015.8 · Cited by 67

PKR Activation in Neurodegenerative Disease

Peel, A. L. (2004) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/63.2.97 · Cited by 67

Deletion of the eIF2α Kinase GCN2 Fails to Rescue the Memory Decline Associated with Alzheimer’s Disease

Devi, L., & Ohno, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0077335 · Cited by 66

Restoring synaptic plasticity and memory in mouse models of Alzheimer’s disease by PKR inhibition

Hwang, K., Bak, M. S., Kim, S. J., Rhee, S., & Lee, Y. (2017) · Molecular Brain · doi:10.1186/s13041-017-0338-3 · Cited by 66

Roles of Non-Coding RNA in Alzheimer’s Disease Pathophysiology

Olufunmilayo, E. O., & Holsinger, R. M. D. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241512498 · Cited by 68

LiCl Attenuates Thapsigargin-Induced Tau Hyperphosphorylation by Inhibiting GSK-3β In Vivo and In Vitro

Fu, Z., Yang, Y., Song, J., Jiang, Q., Liu, Z.-C., Wang, Q., Zhu, L., Wang, J., & Tian, Q. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-100687 · Cited by 65

Increased Cerebrospinal Fluid Levels of Double-Stranded RNA-Dependant Protein Kinase in Alzheimer's Disease

Mouton‐Liger, F., Paquet, C., Dumurgier, J., Lapalus, P., Gray, F., Laplanche, J., & Hugon, J. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.11.031 · Cited by 67

Activation of PKR Causes Amyloid ß-Peptide Accumulation via De-Repression of BACE1 Expression

ILL‐Raga, G., Palomer, E., Wozniak, M. A., Ramos‐Fernández, E., Bosch-Morató, M., Tajes, M., Guix, F. X., Galán, J. J., Clarimón, J., Antúnez, C., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021456 · Cited by 65

The Common Cellular Events in the Neurodegenerative Diseases and the Associated Role of Endoplasmic Reticulum Stress

Kim, S., Kim, D. K., Jeong, S., & Lee, J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23115894 · Cited by 71

Sleep and memory: The impact of sleep deprivation on transcription, translational control, and protein synthesis in the brain

Lyons, L. C., Vanrobaeys, Y. S., & Abel, T. G. (2023) · Journal of Neurochemistry · doi:10.1111/jnc.15787 · Cited by 69

Activating transcription factor 6 derepression mediates neuroprotection in Huntington disease

Naranjo, J. R., Zhang, H., Villar, D., González, P., Dopazo, X. M., Morón-Oset, J., Higueras, E., Oliveros, J. C., Arrabal, M. D., Prieto, Á., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci82670 · Cited by 61

Prevention of the β-amyloid peptide-induced inflammatory process by inhibition of double-stranded RNA-dependent protein kinase in primary murine mixed co-cultures

Couturier, J., Paccalin, M., Morel, M., Terro, F., Milin, S., Pontcharraud, R., Fauconneau, B., & Page, G. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-72 · Cited by 65

Expression of phosphorylated eukaryotic initiation factor 2 alpha in neuronal apoptosis beta-amyloid toxicity

Chang, R. C., Suen, K., & Ma, E. (2001) · The HKU Scholars Hub (University of Hong Kong)

Involvement of double‐stranded RNA‐dependent protein kinase and phosphorylation of eukaryotic initiation factor‐2α in neuronal degeneration

Chang, R. C., Suen, K., Ma, C., Elyaman, W., Ng, H., & Hugon, J. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.01237.x · Cited by 180

Activation of eukaryotic initiation factor-2α-kinases in okadaic acid-treated neurons

Kim, S. M., Yoon, S., Choi, J. E., Park, J. S., Choi, J. M., Nguyen, T. T., & Kim, D. H. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.06.016 · Cited by 26

Differential expression of phosphorylated translation initiation factor 2 alpha in Alzheimer’s disease and Creutzfeldt-Jakob’s disease

Ferrer, I. (2002) · Neuropathology and Applied Neurobiology · doi:10.1046/j.1365-2990.2002.t01-1-00410.x · Cited by 52

P3‐344: Activation of eIF2α‐kinases in okadaic acid‐treated neurons

Yoon, S., Kim, S., Choi, J., & Kim, D. (2010) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2010.05.1845